Daniel L. Alkon - Jun 4, 2021 Form 3 Insider Report for Synaptogenix, Inc. (SNPX)

Role: Chief Scientific Officer, Director
Signature: /s/ Daniel L. Alkon
Stock symbol: SNPX
Transactions as of: Jun 4, 2021
Transactions value $: $0
Form type: 3
Date filed: 6/14/2021, 08:15 PM
Next filing: Jun 16, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SNPX	Common Stock, par value $0.0001 per share						1.48K	Jun 4, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	SNPX	Stock Option (Right to Buy)							Jun 4, 2021	Common Stock, par value $0.0001 per share	31.3K	$9.84	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The holder's options become exercisable as follows: (i) 50% of the options shall become exercisable immediately on January 13, 2021 and (ii) 50% of the options shall become exercisable upon the holder's completion of one year of service following January 13, 2021.